TIDES USA: Oligonucleotide & Peptide Therapeutics is an annual conference dedicated to oligonucleotide and peptide, covering the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing in early discovery to late-stage development and commercialization.
We are excited to announce TIDES USA will return to Boston in 2022 as a hybrid event, accommodating for both in-person and virtual attendees. We hope you will join GenScript and our presentation on peptide-based drug development as we continue to celebrate our community and the advancement of drug discovery and biotechnology innovation.
Topic: Drug Development Using Designed Cyclic Peptides
Patrick Finneran is Senior Scientist at Menten AI. He received his PhD from Brandeis University where his research was focused on the evolution of Non-Receptor Tyrosine Kinases and their regulation and specificity in regard to a wide variety of natural and synthetic peptides. At Menten AI, Patrick helps lead the team responsible for characterizing the computationally designed cyclic peptides using biochemical, biophysical, and pharmacological assays.